XML 49 R33.htm IDEA: XBRL DOCUMENT v3.19.1

Preferred and Common Stock Warrants (Tables)

3 Months Ended

Mar. 31, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Warrant to Purchase Redeemable Convertible Preferred Stock

As of March 31, 2019, the Company’s outstanding warrants to purchase shares of common stock consisted of the following:

Issuance Date		Number of Shares of Common Stock Issuable				Exercise Price				Classification				Expiration Date
August 14, 2015			81,228			$	21.78				Equity				August 14, 2020
August 21, 2015			69,603			$	21.78				Equity				August 21, 2020
October 25, 2016			5,155			$	19.78				Equity				October 24, 2026
November 1, 2017			130,609			$	19.78				Equity				October 31, 2020
November 17, 2017			8,442			$	19.78				Equity				November 16, 2020
December 4, 2017			5,661			$	19.78				Equity				December 3, 2020
December 28, 2017			6,925			$	19.78				Equity				December 27, 2020
December 28, 2017			115,916			$	19.78				Equity				December 28, 2027
September 12, 2018			25,275			$	19.78				Equity				September 12, 2021
September 12, 2018			20,220			$	19.78				Equity				September 12, 2028
October 19, 2018			20,016			$	19.78				Equity				October 19, 2028
December 11, 2018			5,004			$	19.80				Equity				October 19, 2028
			494,054

As of December 31, 2018, the Company’s outstanding warrants to purchase shares of preferred stock (which converted into warrants to purchase common stock upon close of the Merger) consisted of the following (not adjusted for the Reverse Stock Split or Exchange Ratio):

December 31, 2018

Warrant Name

Issuance Date

Number of Shares of Preferred Stock Issuable

Exercise Price

Exercisable for

Classification

Expiration Date

Series A warrants

August 14, 2015

854,785

$

2.07

Series A

Liability

August 14, 2020

Series A warrants

August 21, 2015

732,453

$

2.07

Series A

Liability

August 21, 2020

SVB warrants

October 25, 2016

54,256

$

1.88

Series A

Liability

October 24, 2026

Series B warrants

November 1, 2017

1,374,435

$

1.88

Series B

Liability

October 31, 2020

Series B warrants

November 17, 2017

88,845

$

1.88

Series B

Liability

November 16, 2020

Series B warrants

December 4, 2017

59,576

$

1.88

Series B

Liability

December 3, 2020

Series B warrants

December 28, 2017

72,875

$

1.88

Series B

Liability

December 27, 2020

Series B warrants

December 28, 2017

1,219,815

$

1.88

Series B

Liability

December 28, 2027

Series B warrants

September 12, 2018

265,957

$

1.88

Series B

Liability

September 12, 2021

Series B warrants

September 12, 2018

212,765

$

1.88

Series B

Liability

September 12, 2028

Series B warrants

October 19, 2018

210,638

$

1.88

Series B

Liability

October 19, 2028

5,146,400

X

- References

No definition available.

+ Details

Name:	us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration